Selling and Marketing Expense of Caris Life Sciences, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Caris Life Sciences, Inc. annual and quarterly Selling and Marketing Expense in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • Caris Life Sciences, Inc. Selling and Marketing Expense for the quarter ending 30 Sep 2025 was $41,267,000, a 12% increase year-over-year.
  • Caris Life Sciences, Inc. annual Selling and Marketing Expense for 2025 was $167,506,000, a 9.8% increase from 2024.
  • Caris Life Sciences, Inc. annual Selling and Marketing Expense for 2024 was $152,602,000, a 6.8% increase from 2023.
Source SEC data
View on sec.gov
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Change (%)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $167,506,000 +$14,904,000 +9.8% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $152,602,000 +$9,677,000 +6.8% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $142,925,000 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY

Caris Life Sciences, Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $41,267,000 +$4,509,000 +12% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $42,260,000 +$3,550,000 +9.2% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 $36,758,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $38,710,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.